跳至主要内容
临床试验/DRKS00010108
DRKS00010108已完成不适用

Observational study to assess clinical outcomes and patient satisfaction after multifocal IOL implantation

Optana GmbH0 个研究点目标入组 28 人开始时间: 2016年3月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
45 Years 至 75 Years(—)
性别
All

入选标准

  • Patients must have read, understood and signed the Patient Information (Informed Consent Form)
  • Patients that underwent uneventful refractive surgery (LASIK, PRK) after cataract surgery can be included
  • Only patients that underwent uneventful cataract surgery with a bilateral implantation of multifocal IO

排除标准

  • Existing posterior capsule opacity (PCO) at the day of study examination
  • The time between the surgeries of both eyes is maximum 3 months
  • Clinically significant glaucoma
  • Clinically significant macular degeneration, clinically significant macular edema or proliferative diabetic retinopathy
  • Patients with keratoconus or keratectasia
  • Patients who are pregnant or nursing
  • Abnormal examination results from slit lamp, fundus examination or IOL Master, topography, age related changes are acceptable
  • Patients who do not give informed consent

研究者

发起方
Optana GmbH

相似试验

Observational study to assess clinical outcomes and... | 临床试验